Chai Sue Lee, John Koo
Index: Journal. of. Drugs in. Dermatology. 8(8) , 751-5, (2009)
Full Text: HTML
This study compared the efficacy of a novel, topical class I synthetic, 0.10% fluocinonide corticosteroid with two other class I corticosteroids and placebo for the treatment of plaque psoriasis.A 0.5 gram dose of fluocinonide 0.1% cream, clobetasol propionate 0.05% cream, halobetasol propionate 0.05% cream, and placebo ointment were applied to test sites on one psoriatic plaque per patient (n=5). Test sites were outlined according to the Scholtz-Dumas bioassay. Test sites were assessed by a blinded evaluator (1 = psoriasis worsened to 5 = psoriasis clear or almost clear), cleaned and medications were reapplied on days 3, 5, 7, 10 and 12.The three class I corticosteroid products were comparably effective, numerically and statistically, in clearing the psoriatic plaques. Upon completion of treatment, 60-80% of active-treated sites were clear or almost clear of psoriasis compared to zero with the placebo.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
FLUOCINONIDE
CAS:356-12-7 |
C26H32F2O7 |
Effects of a novel formulation of fluocinonide 0.1% cream on...
2011-02-01 [Journal. of. Drugs in. Dermatology. 10(2) , 171-6, (2011)] |
Urticarial hypersensitivity reaction caused by temozolomide.
2010-09-01 [Journal. of. Drugs in. Dermatology. 9(9) , 1142-4, (2010)] |
In vivo determination of the skin atrophy potential of the s...
2008-01-01 [Journal. of. Drugs in. Dermatology. 7(1) , 28-32, (2008)] |
Reticulated phototoxic eruption in a patient on long-term di...
2008-08-01 [Journal. of. Drugs in. Dermatology. 7(8) , 792-3, (2008)] |
Improvement in treatment adherence with a 3-day course of fl...
2010-10-01 [Cutis. 86(4) , 208-13, (2010)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved